-
SAMU SummariesNo resources currently available.
-
Guidelines
-
MSF TB Guideline (2014)
-
WHO: Guideline on DRTB (2016)
-
WHO: Companion Handbook to the Guidelines on the Management of DRTBRead moreWHO: Companion Handbook to the Guidelines on the Management of DRTB
-
WHO: The use of delamanid in the treatment of multidrug-resistant tuberculosisRead moreWHO: The use of delamanid in the treatment of multidrug- resistant tuberculosis
-
WHO: The use of bedaquiline in the treatment of multidrug-resistant tuberculosisRead moreWHO: The use of bedaquiline in the treatment of multidrug-resistant tuberculosis
-
endTB Guidelines on the Use of New Drugs in the Management of DRTBRead moreendTB Guidelines on the Use of New Drugs in the Management of DRTB
-
MSF HIV/TB Clinical Guide for Primary Care 2018Read moreManuel clinique MSF VIHTB pour les soins de santé primaires
-
WHO Consolidated Guidelines on DR-TB Treatment (2019)
-
-
Implementation Resources
-
MSF TB Patient Education and Counselling Flipchart: DS-TB, MDR-TB & XDR-TB MessagesRead moreTB Patient Education and Counselling Flipchart: DS-TB, MDR-TB & XDR-TB Messages
-
Counselling toolkit for DRTB (Khayelitsha)
-
WHO: Policy Implementation package for new TB drug introduction (2014)Read moreWHO: Policy Implementation package for new TB drug introduction
-
-
Training ResourcesNo resources currently available.
-
Want to Know More
-
Out of Step: TB policies in 29 countries (2017)
-
Self-administered therapy for DRTB treatment: Experience from MSF Khayelitsha, South AfricaRead moreSelf-administered therapy for DRTB treatment: Experience from MSF Khayelitsha, South Africa
-
Decentralisation of DRTB treatment: Experience from MSF in SwazilandRead moreDecentralisation of DRTB treatment: Experience from MSF in Swaziland
-
endTB Interim Analysis: July 2018
-
MSF DRTB abstracts from the UNION conference 2017Read moreDelamanid for rifampicin resistant tuberculosis an observational cohort study from KhayelitshaAdverse events over 6 months with delamanid in a programmatic setting in KhayelitshaAccelerating access to delamanid for rifampicin-resistant tuberculosis in Khayelitsha, South AfricaEarly safety and efficacy of Bedaquiline and Delamanid combination for drug-resistant TB in Armenia, India and South Africa
-
-
Additional ResourcesNo resources currently available.
-
CorrectionsNo resources currently available.
-
UpdatesNo resources currently available.